2nd Gene Therapy for Ophthalmic Disorders
Evvnt Promotion / evvnt
21.09.2021 - 23.09.2021 Online
Time: 8:00 am - 5:00 pm
Kongressthemen
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Returning in September as a digital event, the 2nd Gene Therapy for Ophthalmic Disorders meeting will target the industry’s translational challenges in targeting both rare and common ophthalmic disorders including wet AMD, dry AMD, DME, IRDs and more.
Discover novel vectors and administration routes for optimal retinal delivery with 30+ world class speakers from the likes of GenSight Biologics, Biogen, Gyroscope Therapeutics, Novartis, Horama and REGENXBIO.
Wissenschaftliche Fach-Gesellschaft
Hanson Wade
Hanson Wade
Anmerkungen
Brochure: https://go.evvnt.com/780504-0?pid=4832
Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
Brochure: https://go.evvnt.com/780504-0?pid=4832
Speakers: Nicolas Ferry, Chief Development Officer, HORAMA, Rei Nakamura, Clinical Country Lead, Biogen and more
Anfragen und Anmeldung:
https://go.evvnt.com/780504-1?pid=4832
Frau Ellie Saunders
Allgemeinmedizin
Veranstalter Kontakt
83 Great Titchfield Street
W1W 6RH London
Großbritannien
83 Great Titchfield Street
W1W 6RH London
Großbritannien
"GOING INTERNATIONAL fördert den Zugang zu Aus-, Fort- und Weiterbildung, unabhängig von sozialen, geographischen und nationalen Grenzen."
